Since the early 1990s researchers have been testing whether that same protective signalling does anything elsewhere: rodent and cell studies have looked at whether it prompts new blood vessels to grow into damaged tissue, since a fresh blood supply is what lets repair get started at all
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared either component peptide, or the blend formulation, as a drug for human or veterinary use
Discard your vial immediately if you notice: Cloudiness (Turbidity): A primary sign of bacterial contamination or chemical change
I like the watermelon
Presented for research literature review only Galli F et al
For GHK-Cu, the most defensible dosage discussion comes from published topical study designs and clinical-trial protocols, not from unsourced injectable peptide therapy schedules [2], [3], [7], [8]